Apontis Pharma AG (FRA:APPH)

Market Cap	90.80M
Revenue (ttm)	51.77M
Net Income (ttm)	654.52K
Shares Out	n/a
EPS (ttm)	0.08
PE Ratio	138.72
Forward PE	33.63
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	85
Open	10.95
Previous Close	10.70
Day's Range	10.95 - 10.95
52-Week Range	9.34 - 12.20
Beta	n/a
RSI	64.21
Earnings Date	Nov 18, 2025

About Apontis Pharma AG

Apontis Pharma AG engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany. It offers single pills and other pharmaceutical products with a focus on cardiovascular diseases, such as hypertension, hyperlipidemia, and secondary prophylaxis, as well as respiratory diseases and diabetes. The company was founded in 1946 and is based in Monheim am Rhein, Germany. As of November 21, 2024, Apontis Pharma AG operates as a subsidiary of Zentiva AG.

• Industry: Pharmaceutical Preparations
• Founded: 1946
• Employees: 137
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: APPH